Comparison of the effect of stem cell therapy and percutaneous transluminal angioplasty on diabetic foot disease in patients with critical limb ischemia

0432651 - ÚEM 2015 RIV GB eng J - Článek v odborném periodiku
Dubský, M. - Jirkovská, A. - Bém, R. - Fejfarová, V. - Pagacová, L. - Němcová, A. - Sixta, B. - Chlupáč, J. - Peregrin, J. H. - Syková, Eva - Jude, E. B.
Comparison of the effect of stem cell therapy and percutaneous transluminal angioplasty on diabetic foot disease in patients with critical limb ischemia.
Cytotherapy. Roč. 16, č. 12 (2014), s. 1733-1738. ISSN 1465-3249. E-ISSN 1477-2566
Grant ostatní: GA MZd(CZ) 00023001IKEM
Institucionální podpora: RVO:68378041
Klíčová slova: critical limb ischemia * stem cell therapy * percutaneous transluminal angioplasty
Kód oboru RIV: FH - Neurologie, neurochirurgie, neurovědy
Impakt faktor: 3.293, rok: 2014

The aim of our study was to compare the effect of autologous stem cell therapy (SCT) and percutaneous transluminal angioplasty (PTA) on diabetic foot disease (DFD) in patients with critical limb ischemia (CLI). Our study showed comparable effects of SCT and PTA on CLI, a major amputation rate that was superior to conservative therapy in patients with diabetic foot and an observable effect of SCT on wound healing. Our results support SCT as a potential promising treatment in patients with CLI and diabetic foot.
Trvalý link: http://hdl.handle.net/11104/0239536